Valuation: Procter & Gamble Health Limited

Market Cap 102B 1.07B 928M 866M 795M 1.49B 1.52B 10.14B 3.99B 51.14B 4.03B 3.94B 169B P/E 2026
24.4x
P/E 2027 * 26.6x
Enterprise Value 102B 1.07B 928M 866M 795M 1.49B 1.52B 10.14B 3.99B 51.14B 4.03B 3.94B 169B EV / Sales 2026
5.66x
EV / Sales 2027 * 6.38x
Free-Float
47.81%
Yield 2026 *
-
Yield 2027 * 1.92%
1 day+1.26%
1 week-6.96%
Current month-6.96%
1 month-1.88%
3 months+14.74%
6 months+18.39%
Current year+7.74%
1 week 5,980
Extreme 5980
6,699.5
1 month 5,980
Extreme 5980
6,975
Current year 4,707
Extreme 4707
6,975
1 year 4,707
Extreme 4707
6,975
3 years 4,636.55
Extreme 4636.55
6,975
5 years 3,870.1
Extreme 3870.1
6,975
10 years 686
Extreme 686
7,500
Manager TitleAgeSince
Chief Executive Officer 57 2018-03-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2025-08-31
Director TitleAgeSince
Director/Board Member 57 2018-03-31
Director/Board Member 51 2019-05-31
Chairman 69 2025-03-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%-6.96% - - 1.07B
-0.31%-2.29%+22.57%+69.33% 49.03B
+4.40%+14.46%+62.66%+133.25% 42.33B
-0.89%-0.64%-1.48%+15.58% 12.43B
+0.56%-1.12%+19.02%+70.02% 11.68B
+0.19%+0.39%+31.23%+140.09% 9.12B
+1.99%+4.41%+17.56%+34.79% 7.15B
+1.82%-0.15%+39.41%-13.77% 7.09B
+0.40%+2.02%+12.85%+176.30% 6.76B
+6.44%+8.26%-24.61%+30.64% 5.95B
Average +1.59%+2.78%+19.91%+72.92% 16.84B
Weighted average by Cap. +1.56%+3.77%+30.31%+84.82%

Financials

2026 2027 *
Net sales 13.52B 142M 123M 115M 105M 198M 201M 1.34B 528M 6.77B 533M 522M 22.41B 15.99B 168M 145M 136M 125M 234M 238M 1.59B 624M 8.01B 631M 617M 26.51B
Net income 3.15B 33.06M 28.6M 26.69M 24.51M 46.08M 46.8M 313M 123M 1.58B 124M 121M 5.22B 3.83B 40.23M 34.81M 32.48M 29.82M 56.08M 56.94M 381M 150M 1.92B 151M 148M 6.35B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,326
Date Price Change Volume
26-08-07 ₹6,144.50 +1.26% 25,000
26-08-06 ₹6,068.00 -6.13% 144,705
26-08-05 ₹6,464.50 -0.28% 8,537
26-08-04 ₹6,482.50 -0.29% 5,589
26-08-03 ₹6,501.50 -1.56% 7,179
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise